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Abstract 
 Potrero Hill Health Center through the San Francisco Department of Public Health aims 
to deliver health promotion, disease prevention, heath maintenance, counseling, and health 
education of acute and chronic diseases. Hypertension is a common problem to both the health 
center and to the general population, and Potrero Hill Health Center aims to understand and 
develop a program that will aid in hypertension management at their local clinic. A supplemental 
pharmacist service was implemented at Potrero Hill Health Center to help manage hypertensive 
patients. Systolic and diastolic blood pressure levels were compared in patients receiving 
pharmacist counseling versus those receiving physician services only. Preliminary findings 
demonstrated that when compared to treatment as usual, those receiving supplemental 
pharmacist services had better hypertension control with significant reductions in both systolic 
and diastolic levels. Pharmacist counseling in community health clinics may have a beneficial 
public health impact in controlling hypertension, thus reducing potential complications of 
hypertension such as cardiovascular disease in low-income, minority populations.  
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According to the Centers for Disease Control and Prevention, 70 million American adults 
have hypertension, which translates to about 1 in every 3 adults. Among those, only half have 
their high blood pressure under control (CDC, 2016). Individuals of low socioeconomic status 
and of minority backgrounds are disproportionately affected by hypertension. Community 
safety-net clinics are burdened by low resources and struggle to maintain adequate hypertension 
control in low income and minority patients and reduce health disparities in cardiovascular 
disease in the U.S.  
Background 
Data from the National Health and Nutrition Examination Surveys (NHANES) 1999-
2014 showed that 29.0% of adults had hypertension in 2011-2014 and the prevalence increased 
with age: 18–39, 7.3%; 40–59, 32.2%; and 60 and over, 64.9%, with a similar pattern between 
genders (Carroll et al., 2015). It was also higher among non-Hispanic black (41.2%) than non-
Hispanic white (28.0%), non-Hispanic Asian (24.9%), or Hispanic (25.9%) adults. The 
prevalence of controlled hypertension was 53.0% overall, and those aged 18-39 were less likely 
to have controlled hypertension than those aged 60 and over. Between races, the prevalence of 
control was higher among non-Hispanic white (55.7%) than non-Hispanic black (48.5%), non-
Hispanic Asian (43.5%), or Hispanic (47.4%) adults. Men and women had similar rates of 
control at 29.0% and 30.0% respectively. Among men with hypertension, non-Hispanic white 
(53.8%) adults had a higher prevalence of controlled hypertension compared with non-Hispanic 
black (43.8%), non-Hispanic Asian (39.9%), and Hispanic (43.5%) adults. For women with 
hypertension, the percentage of non-Hispanic white (59.1%) adults with controlled high blood 
pressure was higher than that of non-Hispanic black (52.3%) and non-Hispanic Asian (46.8%) 
adults (Carroll et al., 2015). 
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Hypertension is a major cause of illness and disability and significantly increases the risk 
for heart disease and stroke – two leading causes of death in the United States (CDC, 2016). 
While heart disease and stroke are among the most preventable diseases, they are also the most 
widespread and costly, accounting for hundreds of billions of dollars annually through healthcare 
expenditures and lost productivity. Hypertension alone cost the nation $46 billion annually, 
including the cost of health care services, medications to treat hypertension, and missed days of 
work. Additionally, it is a primary or contributing cause of death of more than 360,000 
Americans each year (CDC, 2016). 
Lack of education and understanding may be a barrier to adequate hypertension control. 
From 2011-2012, 82.7% of those with hypertension were aware that they had it, and 75.6% 
reported currently taking prescribed medications to lower their blood pressure, while only 51.8% 
had it under control (Burt et al., 2013). Taking antihypertensive medications was higher in 
women (80.6%) than men (70.9%) and increased with age: 44.5% for those aged 18–39, 73.7% 
for those 40–59, and 82.2% for those 60 and over. Non-Hispanic Asian adults were less likely to 
report taking antihypertensive medication (65.2%) than were non-Hispanic black (77.4%) and 
non-Hispanic white (76.7%) adults (Burt et al., 2013). This highlights that prescribing 
medication alone is not sufficient in controlling hypertension. While the control rate has 
increased from 29% in 1999 to an upwards of 54%, there is still room for improvement to meet 
the Healthy People 2020 goal of 61.2% (Carroll et al., 2015). 
 The American Heart Association has several recommendations on how to prevent and 
treat hypertension. Primary prevention begins with understanding one’s risk factors, such as race, 
age, family history, comorbidities, and unhealthy habits. Secondary prevention involves having 
blood pressure checked and accurately diagnosed by a healthcare professional. Lifestyle changes 
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to adopt are part of both primary and tertiary prevention, including eating a healthier diet and 
reducing salt intake, engaging in regular physical activity, maintaining a healthy weight, 
managing stress, and avoiding or limiting tobacco smoke and alcohol. In addition, tertiary 
prevention includes compliance with medication if taken (American Heart Association, 2016). 
Pharmacists Role in Hypertension Control 
 There has been limited but promising results with use of a pharmacist in aiding in blood 
pressure control and management amongst hypertensive patients in primary care settings. 
Whether a pharmacist was utilized in collaboration with a physician or more independently, the 
literature supports pharmacist roles as a significant factor in the care of hypertensive adults. 
Through pharmacist-lead clinics that focus on blood pressure, patients can receive individualized 
care towards their hypertension management, including proper titration of medications and closer 
monitoring of adherence to their medications, diets, and lifestyle habits. In a study conducted by 
Hunt et al. (2008), subjects who received the intervention of pharmacist-lead blood pressure 
consults achieved significantly lower systolic (Δ = 6 mmHg, p = 0.007) and diastolic 
(Δ = 3 mmHg, p = 0.002) blood pressures compared to control subjects (137/75 mmHg vs. 
143/78 mmHg). In addition, 62% of those receiving the intervention achieved target blood 
pressure compared to 44% of those who did not (p = 0.003). The odds of achieving blood 
pressure target in the intervention group were 2.08 times higher than the control group. These 
results have been consistent in many studies that include pharmacists to manage blood pressure 
in primary care settings. In another study conducted by Carter et al. (2015), blood pressure 
control rate monitored after discontinuation of a pharmacist-lead program in a Veterans Health 
Administration setting. After 6 months, blood pressure remained to be controlled at a rate above 
50%, but did not sustain over longer periods of time. 
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 Based on research evidence, a “Blood Pressure Clinic” was implemented at an urban 
primary care community clinic to examine the effectiveness of a pharmacist lead hypertension 
management program. This paper reports on a preliminary evaluation of the “Blood Pressure 
Clinic” that aimed to increase blood pressure control in a predominately low income minority 
population with hypertension. 
Potrero Hill Health Center: An Urban Safety Net Clinic 
Potrero Hill Health Center (PHHC) is a primary care clinic located in San Francisco, 
California, in affiliation with the San Francisco Department of Public Health (SFDPH) and San 
Francisco General Hospital. It is among 12 clinics that provide primary care for adults, and 
includes services for pharmacy, nutrition, and mental, dental, and prenatal health. The overall 
mission of the SFDPH is to protect and promote the health of all San Franciscans, and through 
the help of clinics such as PHHC, patients can receive family-centered, comprehensive, and 
team-based care that is focused on quality and safety. The clinic is focused on delivering health 
promotion, disease prevention, heath maintenance, counseling, health education, and diagnosis 
and treatment of acute and chronic diseases. The target population of PHHC is minority adults of 
low-socioeconomic class. Amongst ethic backgrounds, 33.01% are Hispanic/Latino, 23.77% are 
Black/African American, 18.46% are White/Caucasian, 13.32% are Asian, 1.99% are Native 
Hawaiian, and the remaining 9.45% Other. Hypertension and diabetes are the most common 
morbidities seen at the clinic, with a prevalence of 35.17% and 15.99% respectively. The current 
blood pressure control rate is 65.8% among hypertensive adults at the clinic. 
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Evaluation of the Blood Pressure Clinic 
Purpose 
The purpose of the project was to examine whether utilizing a pharmacist-lead blood 
pressure clinic (BP Clinic) involving medication titration and health education would improve 
blood pressure control in hypertensive patients at the Potrero Hill Health Center.  
Hypothesis 
Individuals who attend at least one pharmacist-lead blood pressure session will have 
better blood pressure control than those who are provided usual care in a one-year period. 
Methods and Criteria 
Hypertensive patients at Potrero Hill Health Center in San Francisco, CA were observed over 
the course of a year, from July 2015-September 2016. Blood pressure readings were collected 
and analyzed at 3, 6, and 12-month intervals. Hypertensive patients were defined as those who 
had hypertension listed on their problem list on their electronic medical record (EMR). Blood 
pressure control was defined according to the Joint National Committee 8 (JNC-8) guidelines as:  
• Age < 60 years without diabetes mellitus, chronic kidney disease, or other major 
comorbidities: < 140/90mmHg  
• Age 60 years or older without diabetes mellitus, chronic kidney disease, or other major 
comorbidities: < 150/90mmHg  
• Age 18 years or older with diabetes mellitus, chronic kidney disease, or both:                  
< 140/90mmHg 
Individuals who met the JNC-8 criteria were considered at goal. Those whose systolic or 
diastolic were higher than the JNC-8 criteria were considered above goal. 
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Starting July 2015, hypertensive patients at the clinic who had blood pressure levels 
above goal were referred to the pharmacist-lead blood pressure session held at the clinic once a 
week. Referrals were made by their primary care providers at regular appointments or through 
telephone outreach encounters. Patients in the usual care arm were not referred by primary care 
provider, or did not attend a BP clinic session after a referral. Demographic data including age, 
race/ethnicity, and diabetes and chronic kidney disease status were collected on those who 
attended BP Clinic and those who did not. 
BP Clinic was held once a week at PHHC on Fridays, with an average of 3-4 sessions per 
month. It was lead by a single pharmacist who had access to patients’ EMR and knowledge of 
their clinical history. Each session included taking a blood pressure reading, follow-up with 
medication adherence, medication titration and education on recommended diet and exercise 
regimens to improve blood pressure. Outreach calls were made using the hypertension registry 
collect from the health database i2i, which was filtered to patients at PHHC, patients with 
hypertension on their problem list according to EMR, and patients who had at least one blood 
pressure reading above goal defined as SBP >/= 140 or DBP >/= 90 from January 1, 2015 – 
September 31, 2016. A total of 120 patients were in the BP clinic cohort and 296 in the usual 
care cohort. Among the BP clinic cohort, baseline blood pressure was determined by the most 
recent reading prior to their first BP Clinic session that was above goal. Among the usual care 
cohort, baseline blood pressure was determined by a reading above goal on or before September 
2016. Using the date of the baseline blood pressure, 3, 6, and 12-month intervals were taken 
from there. Due to the observational method of collection, it was likely that patients did not have 
a reading at a certain time interval. In that case patients were not excluded from the study; rather, 
there was just one less data point to utilize for that time interval. At the end of the one-year 
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study, any patient (usual care group) who did not have a 12-month blood pressure listed was 
substituted with the most recent reading available within the study time frame. For both cohorts, 
a single blood pressure reading was utilized for each time interval. If multiple readings existed, 
the last one was used.
The following outcomes were measured: primary—comparing the percentage of patients 
with blood pressure control as defined by the JNC-8 guidelines between those who attended BP 
Clinic and those who did not after 12 months; secondary—comparing demographic differences 
observed between the two cohorts. 
Statistical Analyses 
Two independent sample t-tests were used to test whether the average difference between 
the two cohorts were significant or due to random chance. Excel software and Google calculator 
were used to compute data.  
Results 
Patients who attended at least one session of BP Clinic had a greater percentage of blood 
pressure control as defined by the JNC-8 Guidelines at the end of one year (71.67% vs. 53.04%, 
see Table 1). Overall average systolic and diastolic blood pressure in both cohorts were 
considered at goal, or below 140 and 90, at the end of one year. However, when looking at 
individual cases, average systolic blood pressure in the BP Clinic cohort was 134.9 mmHg 
compared to 139.1 mmHg in the usual care cohort, and the difference was significant at the alpha 
= 0.05 level, df = 414, t = -1.649 (t = -2.027, p = 0.021651). Average diastolic blood pressure 
was 78.0 mmHg in the BP clinic cohort compared to 84.6 mmHg in the usual care cohort, and 
was significant at the alpha = 0.05 level, df = 414, t = -1.649, (t = -5.540, p < 0.00001). Average 
change in systolic and diastolic blood pressure was greater among the BP clinic cohort compared 
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to usual care (SBP Δ19.43mmHg vs. 16.45mmHg; DBP Δ9.23 vs. 8.50) (See Figure 1-4). In 
both cohorts, African Americans were the most prevalent. Asian was the second most prevalent 
in the BP Clinic cohort, while White was second in the usual care cohort. Hispanic/Latino was 
third most prevalent for both cohorts. There were also a larger percentage of patients who had 
diabetes or chronic kidney disease among those who attended BP Clinic compared to usual care 
(49.17% vs. 35.47%).
Table 1: Blood Pressure Control and Demographics 
BP CONTROL AT 1 YEAR 
 BP Clinic % Non-BP Clinic % 
Yes 71.67 53.04 
No 28.33 46.96 
 
BLACK/AFRICAN AMERICAN BP CONTROL AT 1 YEAR 
 BP Clinic % Non-BP Clinic % 
Yes 61.36 48.21 
No 38.64 51.79 
 
RACE/ETHNICITY 
 BP Clinic % Non-BP Clinic % 
Black/African American 36.67 37.84 
White 10.0 16.55 
Hispanic/Latino 15.83 16.22 
Asian 19.17 15.20 
Native Hawaiian/ Other Pacific 
Islander 
2.50 3.38 
Other/Refused 15.83 10.81 
 
 
DISEASE STATUS 
 
 
 
 
 
 
 
 BP Clinic Non-BP Clinic 
YES Diabetes/ 
Chronic Kidney Disease 
59 105 
NO Diabetes/ 
Chronic Kidney Disease 
61 191 
Total 120 296 
Percent Yes 49.17% 35.47% 
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Figure 1: BP Clinic
 
 
Figure 2: Usual Care 
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Figure 3: BP Clinic vs. Usual Care Line 
Figure 4: BP Clinic vs. Usual Care Column 
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Limitations 
 
This evaluation had many strengths including no additional cost to perform the study and 
use of the same pharmacist, which promoted consistency. However, several limitations also 
existed. Patient attendance could not be predicted or controlled, which resulted in data gaps at 
certain time periods. Additionally, the method of data collection could have been influenced by 
behavioral factors. Blood pressure measurements are sensitive and change according to posture, 
exercise, sleep, stress, mental health, caffeine, and smoking. Utilizing a single event reading on 
does not necessarily indicate the patient average blood pressure control. Recommended 
guidelines to accurately diagnose hypertension include averaging 2-3 readings after a patient has 
been sitting quietly for five minutes. In this study we could not control for environmental factors 
and used the last single blood pressure reading rather than an average. Lastly, missing data was 
not replaced or omitted, so each time interval represented a different cohort. 
An important factor to consider is that there were a higher percentage of diabetic/chronic 
kidney disease patients in the BP Clinic cohort. Patients who have symptomatic comorbidities 
such as diabetes and chronic kidney disease may tend to be more involved with their personal 
health, compared to those with a sole diagnosis of hypertension therefore are more likely to seek 
medical care. Behavioral modifications and treatments that patients with diabetes/chronic kidney 
disease are already utilizing can also have a positive effect on their blood pressure.  
Public Health Significance 
Interventions that include pharmacists to improve blood pressure control in hypertensive 
adults have shown promising results. In many primary care settings physicians have limited face-
to-face time with patients to discuss comprehensive blood pressure management.  
Utilizing ancillary clinic staff such as clinical pharmacists to titrate medications and reinforce
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medication adherence and lifestyle changes should be used as a best practice method for 
hypertension management in order to meet the Healthy People 2020 goal of 61.2%. Improving 
blood pressure control also closes the gap in health disparities by reducing cardiovascular disease 
and increases cost savings of the nation. 
Conclusion 
Hypertension management is imperative because it is common in the population, 
especially among low-income, underserved populations, which are frequently the target 
population when we address any public health issue. The potential consequences of uncontrolled 
or untreated hypertension not only affect the people who have it, but also the people who are 
around them such as friends and family. Further attention about education is imperative not only 
to the disease itself, but for the general health of our population. Promoting lifestyle changes 
such as eating a healthy diet and engaging in regular physical activity is applicable to overall 
improved health, and has shown to be a positive effect on mental health, women and children’s 
health, improved performance at school, and so forth. It is a disease that everyone should be 
aware of, and one that everyone should understand how to prevent or treat.  
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Purpose 
D
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ents 
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R
esults 
Lim
itations 
W
eaknesses 
H
unt et 
al. 
2008 
Pharm
acist 
practitioners 
vs. usual care 
in 
hypertension 
m
anagem
ent, 
com
m
unity-
based setting 
Single-
blind, 
R
C
T 
 
M
ailed 
invitations, self-
reported 
questionnaires, 
appropriate sized 
cuffs and 
standard m
ercury 
sphygm
om
anom
eter 
A
 total of 463 
subjects 
(n = 233 
control, 
n = 230 
intervention) 
 
Subjects in the intervention arm
 had 
significantly low
er systolic and 
diastolic blood pressures com
pared 
to control, 62%
 of intervention 
subjects achieved target blood 
pressure com
pared to 44%
 of 
control subjects. M
inim
al 
differences betw
een groups in 
hypertension-related know
ledge, 
m
edication adherence, quality of 
life, or satisfaction. 
 
Single-blind study, 16%
 response rate, 
com
bination drug therapy in the 
intervention arm
 
W
al et al.  
2013 
Pharm
aceutica
l care (patient 
education, 
prescription 
assistance, and 
the life style 
m
odifications) 
vs. none 
R
C
T 
Short Form
-36 
quality of life 
questionnaire, 
pictogram
s, 
interview
s 
20 to 75 years 
old, 102 total, 
(n = 48 
control, n = 54 
intervention)  
Intervention arm
 had significantly 
low
er systolic and diastolic blood 
pressures com
pared to the control 
arm
, and also had better m
ean score 
on the quality of life questionnaire.  
B
aseline blood pressure w
as com
pared to 
1
st follow
-up and 2
nd follow
-up 
m
easurem
ents, how
ever, length of tim
e 
betw
een appointm
ents not specified  
 
C
arter et 
al. 
2015 
Exam
ine blood 
pressure 
control after 
discontinuatio
n of 
pharm
acist-
m
anaged 
intervention 
R
C
T 
10-item
 Pfeiffer 
Short Portable 
M
ental Status 
Q
uestionnaire, 
autom
ated B
P 
m
achine 
 
Iow
a V
eterans 
A
dm
inistration
, 123 total 
participated 
(62 stop 
intervention, 
61 continue 
intervention) 
Significant decrease in blood 
pressure am
ong those w
ho 
continued the intervention after 6 
m
onths. D
ata for 12, 18, and 24-
m
onth intervals w
ere not 
statistically significant to conclude 
(p>0.1) 
U
nable to generalize to population outside 
the V
A
; patients w
ere largely m
ale, 
M
idw
estern, and C
aucasian; high p-
values 
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	 Hirsh et 
al. 
2014 
Pharm
acist 
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vs. usual care 
in  
R
C
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C
linical 
collaborative 
practice protocol, 
m
anual w
all-
m
ounted 
sphygm
om
anom
eter 
 
A
ge 18 and 
older, n = 75 
intervention 
arm
, n = 91 
control  
M
ore patients in the intervention arm
 
w
ere at blood pressure goal at 6 and 
9 m
onths com
pared to usual care. 
R
eduction in average B
P w
as also 
greater in the intervention at 6 
m
onths, but w
as not statistically 
significant at 9 m
onths 
N
ot generalizable due to single 
university-based general internal 
m
edicine practice; patient had to be able 
to speak, read, and w
rite English; 
patients received sm
all paym
ents for 
each clinic visit; participation bias 
because those w
ho w
ere in the 
intervention knew
 that they w
ere and 
those in usual care did not 
 
C
arter et 
al.  
2015 
Physician/phar
m
acist 
collaborative 
m
odel prim
ary 
care m
edical 
offices across 
15 states 
 
Prospec
tive, 
cluster-
random
i
zed trial 
Survey to score 
clinical 
pharm
acy 
services  
625 total 
subjects (n = 
401 
intervention, n 
= 224 control)  
 
B
lood pressure not controlled (not 
statistically significant), how
ever, 
reduction in m
ean blood pressure 
w
as greater in the intervention arm
 
than control 
O
nly generalizable to sim
ilar settings, 
subjects involved w
ere not m
asked 
Santschi 
et al. 
2014 
Pharm
acist 
interventions 
(alone or in 
collaboration 
w
ith other 
healthcare 
professionals) 
M
eta-
analysis 
of R
C
Ts 
M
ED
LIN
E, 
EM
B
A
SE, 
C
IN
A
H
L, and 
C
EN
TR
A
L 
databases 
39 R
C
Ts 
representing 
14,224 
patients, trials 
w
ere published 
betw
een 1973 
and 2013 in 
peer-review
ed 
journals 
C
om
pared w
ith usual care, 
pharm
acist interventions show
ed 
greater reduction in systolic and 
diastolic blood pressure. The effect 
tended to be larger if the intervention 
w
as led by the pharm
acist and w
as 
done at least m
onthly. 
Publication bias, sm
all studies show
ing 
w
eak or no effect m
ay not have been 
published 
B
odgen 
et al. 
1998 
Physician and 
pharm
acist 
team
w
ork 
approach 
Single-
blind, 
R
C
T 
n = 49 
intervention, n = 
46 control 
Interview
s, 
JN
C
-5 
guidelines 
M
ore than double the percentage of 
those in the intervention arm
 
achieved blood pressure control 
com
pared to control, w
ith greater 
decline in diastolic and systolic blood 
pressures 
Sm
all sam
ple, random
ization not 
guaranteed, even or odd last digit SSN
 
w
as entered by a person, w
ho could 
easily figure out the pattern 
M
ontgom
ery et al.  
2001 
C
om
pare 
patient 
preferences of 
treatm
ent to 
recom
m
ended 
guidelines  
O
bserva
tional 
study  
Interview
s  
52 patients 
responded to 
invitation (out 
of 100), w
hich 
w
ere chosen 
random
ly 
Individuals vary w
idely in their 
preferences for possible outcom
es, 
m
arked disagreem
ent w
ith results 
from
 decision analysis 
Low
 response rate, chose to participate  
U
SE O
F PH
A
R
M
A
C
ISTS IN
 M
A
N
A
G
EM
EN
T O
F H
Y
PER
TEN
SIO
N
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	    Heymann 
et al.  
2012 
Explore beliefs 
and 
perceptions of 
hypertension, 
gain 
understanding 
of barriers 
Q
ualitat
ive 
study  
Focus groups 
10 focus 
groups, 86 
total people 
Participants saw
 hypertension has a 
risk factor for M
I or stroke, rather 
than a disease. V
iew
ed as a binary 
risk process (have it or not) rather 
than a continuous, degenerative 
process. D
iabetic patients m
ore likely 
to accept hypertension as a chronic 
illness w
ith m
inor im
pact on their 
routine, and less im
portant than their 
diabetes. Stress w
as overestim
ated as 
the m
ost im
portant causative factor. 
Participants w
ere agreeable to 
participate, m
ay have high health 
aw
areness, doesn’t highlight the extent 
of non-adherence of hypertension 
Jolles et 
al. 
2013 
A
ssess 
know
ledge and 
beliefs of 
hypertension 
Q
ualitat
ive 
study 
Sem
i structured 
interview
s w
ith 
topic guide, 30-
60 m
inutes 
A
ge 18 older, 
26 total 
patients 
O
nly half of patients w
ere able to 
recall optim
al or target blood 
pressure.  
The m
ajority could recall 
consequences of hypertension. 
Patients aw
are of the im
pact of 
lifestyle m
odifications, how
ever, 
failed to translate this into 
im
plem
entation. A
 lack of a routine 
for m
edication use w
as the m
ost 
frequently reported barrier to proper 
B
P control. Physicians too busy to 
answ
er questions, 69%
 received 
m
ore inform
ation from
 another 
healthcare professional. 
Sm
all sam
ple, participants agreed to 
participate (participation bias) 
A
ppel 
2003 
Lifestyle 
m
odifications 
to control 
blood pressure 
R
eview
 
article 
 
 
Increasing physical activity, 
m
aintaining healthy body w
eight, 
m
oderate alcohol intake, diet high in 
fruits, and vegetables, potassium
 and 
low
 in fat and salt 
 
C
ollier 
and 
Landram
 
2012 
M
edications 
and/or lifestyle 
R
eview
 
article 
 
 
C
onsider w
hite coat hypertension 
(increased blood pressure w
hen a 
clinician is present) 
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Appendix B. Competencies & Goals & Objectives 
 
Competencies Achieved 
 
 Throughout this fieldwork I completed learning objectives that contributed to my 
achievement in the University of San Francisco’s Master of Public Health competencies, 
including: 
1. Assessing, monitoring, and reviewing the health status of populations and their related 
determinants of health and illness 
2. Demonstrating the ability to utilize the proper statistical and epidemiologic tools to assess 
community needs and program outcomes 
3. Identifying and prioritizing key dimensions of a public health problem by critically assessing 
the public health literature 
4. Demonstrating leadership abilities and effectively communicating with partners as a 
collaborator of evidence-based public health projects 
 
Goals and Objectives 
 
Goal 1: Identify and Explore a Public Health Problem at Potrero Hill Health Center (PHHC) 
Objectives Activities Timeframe Who is 
Responsible 
Tracking Measures 
Identify which 
morbidities are the 
most prevalent at 
PHHC 
Ask providers and 
staff about most 
common problems 
in the population 
Mar 22 - Apr 12 Pandora and 
appropriate staff 
Provided list of 
most common 
problems  
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Understand why 
the problem exists, 
intervention and 
best-practices to 
combat the 
problem 
Conduct literature 
review 
Mar 22 - Sep 22 Pandora Read lit reviews 
 
Goal 2: Understand the Importance of Engaging and Maintaining Communication with Partners 
Objectives Activities Timeframe Who is 
Responsible 
Tracking Measures 
Have at least one 
30-minute meeting 
with preceptor 
once a week while 
on site 
Communicate on-
site days with 
preceptor to set 
meeting up 
Mar 22 - Nov 3 Pandora and 
Preceptor 
Notes taken from 
meeting 
Communicate via 
email as needed  
Email questions 
concerns when 
preceptor or 
student unavailable 
for meetings 
Mar 22 - Nov 3 Pandora and 
Preceptor 
Email exchanges 
 
Goal 3: Understand Different Data Analyses Techniques and Appropriately Utilize Towards a Quality Improvement 
Project 
Objectives Activities Timeframe Who is 
Responsible 
Tracking Measures 
Explore the 
different types of 
studies and 
methods used 
Conduct literature 
review 
Mar 22- Nov 3 Pandora Read lit reviews 
Collect and 
organize data 
Create 
spreadsheets, 
tables, and graphs 
Mar 22- Nov 3 Pandora Spreadsheets, 
tables, and graphs 
made 
Conduct analyses 
for conclusion 
Identify and 
perform test 
Jul 6 - Nov 3 Pandora Results and p-
values 
 
Goal 4: Increase Participation Rates of Current Programs at PHHC 
Objectives Activities Timeframe Who is 
Responsible 
Tracking 
Measures 
Assess current 
participation rates 
and outreach 
strategies of 
programs 
Ask providers and 
staff for data on 
participation rate 
Mar 22 - Nov 3 Pandora and 
appropriate staff 
List of rates 
Determine 
preferred method 
of communication 
among patients 
Ask providers and 
front desk to 
include 
communication 
preferences during 
visit 
Mar 22 - Sept 22 Pandora and 
appropriate staff 
Preferred method 
listed in medical 
record chart 
Broaden scope of 
outreach 
Create new flyers 
for existing 
programs 
Mar 22 - Sep 19 Pandora Flyers made 
	
